“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
StockStory.org on MSN
TXG Q2 deep dive: Atera launch signals transition as spatial market shifts
Biotech company 10x Genomics (NASDAQ:TXG) reported Q2 CY2026 results , but sales fell by 12.6% year on year to $151 million.
Proteintech Genomics brings deep expertise and differentiated technologies for measuring proteins in multi-omics context. We believe integrating rich proteomic information alongside spatial ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results